Cargando…

Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare

BACKGROUND: The increase in antimicrobial resistance is of worldwide concern. Surrogate tracers attempt to simulate microbial transmission by avoiding the infectious risks associated with live organisms. We evaluated silica nanoparticles with encapsulated DNA (SPED) as a new promising surrogate trac...

Descripción completa

Detalles Bibliográficos
Autores principales: Scotoni, Manuela, Koch, Julian, Julian, Timothy R., Clack, Lauren, Pitol, Ana K., Wolfensberger, Aline, Grass, Robert N., Sax, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493369/
https://www.ncbi.nlm.nih.gov/pubmed/32938493
http://dx.doi.org/10.1186/s13756-020-00813-7
_version_ 1783582554715062272
author Scotoni, Manuela
Koch, Julian
Julian, Timothy R.
Clack, Lauren
Pitol, Ana K.
Wolfensberger, Aline
Grass, Robert N.
Sax, Hugo
author_facet Scotoni, Manuela
Koch, Julian
Julian, Timothy R.
Clack, Lauren
Pitol, Ana K.
Wolfensberger, Aline
Grass, Robert N.
Sax, Hugo
author_sort Scotoni, Manuela
collection PubMed
description BACKGROUND: The increase in antimicrobial resistance is of worldwide concern. Surrogate tracers attempt to simulate microbial transmission by avoiding the infectious risks associated with live organisms. We evaluated silica nanoparticles with encapsulated DNA (SPED) as a new promising surrogate tracer in healthcare. METHODS: SPED and Escherichia coli were used to implement three experiments in simulation rooms and a microbiology laboratory in 2017–2018. Experiment 1 investigated the transmission behaviour of SPED in a predefined simulated patient-care scenario. SPED marked with 3 different DNA sequences (SPED1-SPED3) were introduced at 3 different points of the consecutive 13 touch sites of a patient-care scenario that was repeated 3 times, resulting in a total of 288 values. Experiment 2 evaluated SPED behaviour following hand cleaning with water and soap and alcohol-based handrub. Experiment 3 compared transfer dynamics of SPED versus E. coli in a laboratory using a gloved finger touching two consecutive sites on a laminate surface after a first purposefully contaminated site. RESULTS: Experiment 1: SPED adhesiveness on bare skin after a hand-to-surface exposure was high, leading to a dissemination of SPED1–3 on all consecutive surface materials with a trend of decreasing recovery rates, also reflecting touching patterns in concordance with contaminated fingers versus palms. Experiment 2: Hand washing with soap and water resulted in a SPED reduction of 96%, whereas hand disinfection led to dispersal of SPED from the palm to the back of the hand. Experiment 3: SPED and E. coli concentration decreased in parallel with each transmission step – with SPED showing a trend for less reduction and variability. CONCLUSIONS: SPED represent a convenient and safe instrument to simulate pathogen spread by contact transmission simultaneously from an infinite number of sites. They can be further developed as a central asset for successful infection prevention in healthcare.
format Online
Article
Text
id pubmed-7493369
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74933692020-09-16 Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare Scotoni, Manuela Koch, Julian Julian, Timothy R. Clack, Lauren Pitol, Ana K. Wolfensberger, Aline Grass, Robert N. Sax, Hugo Antimicrob Resist Infect Control Research BACKGROUND: The increase in antimicrobial resistance is of worldwide concern. Surrogate tracers attempt to simulate microbial transmission by avoiding the infectious risks associated with live organisms. We evaluated silica nanoparticles with encapsulated DNA (SPED) as a new promising surrogate tracer in healthcare. METHODS: SPED and Escherichia coli were used to implement three experiments in simulation rooms and a microbiology laboratory in 2017–2018. Experiment 1 investigated the transmission behaviour of SPED in a predefined simulated patient-care scenario. SPED marked with 3 different DNA sequences (SPED1-SPED3) were introduced at 3 different points of the consecutive 13 touch sites of a patient-care scenario that was repeated 3 times, resulting in a total of 288 values. Experiment 2 evaluated SPED behaviour following hand cleaning with water and soap and alcohol-based handrub. Experiment 3 compared transfer dynamics of SPED versus E. coli in a laboratory using a gloved finger touching two consecutive sites on a laminate surface after a first purposefully contaminated site. RESULTS: Experiment 1: SPED adhesiveness on bare skin after a hand-to-surface exposure was high, leading to a dissemination of SPED1–3 on all consecutive surface materials with a trend of decreasing recovery rates, also reflecting touching patterns in concordance with contaminated fingers versus palms. Experiment 2: Hand washing with soap and water resulted in a SPED reduction of 96%, whereas hand disinfection led to dispersal of SPED from the palm to the back of the hand. Experiment 3: SPED and E. coli concentration decreased in parallel with each transmission step – with SPED showing a trend for less reduction and variability. CONCLUSIONS: SPED represent a convenient and safe instrument to simulate pathogen spread by contact transmission simultaneously from an infinite number of sites. They can be further developed as a central asset for successful infection prevention in healthcare. BioMed Central 2020-09-16 /pmc/articles/PMC7493369/ /pubmed/32938493 http://dx.doi.org/10.1186/s13756-020-00813-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Scotoni, Manuela
Koch, Julian
Julian, Timothy R.
Clack, Lauren
Pitol, Ana K.
Wolfensberger, Aline
Grass, Robert N.
Sax, Hugo
Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare
title Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare
title_full Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare
title_fullStr Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare
title_full_unstemmed Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare
title_short Silica nanoparticles with encapsulated DNA (SPED) – a novel surrogate tracer for microbial transmission in healthcare
title_sort silica nanoparticles with encapsulated dna (sped) – a novel surrogate tracer for microbial transmission in healthcare
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493369/
https://www.ncbi.nlm.nih.gov/pubmed/32938493
http://dx.doi.org/10.1186/s13756-020-00813-7
work_keys_str_mv AT scotonimanuela silicananoparticleswithencapsulateddnaspedanovelsurrogatetracerformicrobialtransmissioninhealthcare
AT kochjulian silicananoparticleswithencapsulateddnaspedanovelsurrogatetracerformicrobialtransmissioninhealthcare
AT juliantimothyr silicananoparticleswithencapsulateddnaspedanovelsurrogatetracerformicrobialtransmissioninhealthcare
AT clacklauren silicananoparticleswithencapsulateddnaspedanovelsurrogatetracerformicrobialtransmissioninhealthcare
AT pitolanak silicananoparticleswithencapsulateddnaspedanovelsurrogatetracerformicrobialtransmissioninhealthcare
AT wolfensbergeraline silicananoparticleswithencapsulateddnaspedanovelsurrogatetracerformicrobialtransmissioninhealthcare
AT grassrobertn silicananoparticleswithencapsulateddnaspedanovelsurrogatetracerformicrobialtransmissioninhealthcare
AT saxhugo silicananoparticleswithencapsulateddnaspedanovelsurrogatetracerformicrobialtransmissioninhealthcare